Back to Authors

Reiman, Eric M.

https://orcid.org/0000-0002-0705-3696

Mayo Clinic

Banner Alzheimer’s Institute

Citations 166

P4‐298: IMPROVING THE POWER TO TRACK FIBRILLAR AMYLOID PET MEASUREMENTS AND EVALUATE AMYLOID‐MODIFYING TREATMENTS USING A CEREBRAL WHITE MATTER REFERENCE REGION‐OF‐INTEREST
Roontiva, Auttawut, Lee, Wendy , Ayutyanont, Napatkamon , Protas, Hillary , Landau, Susan , Luo, Ji , Bauer, Robert, Reschke, Cole, Bandy, Dan, Fleisher, Adam , Caselli, Richard J., Jagust, William J. , Weiner, Michael W. , Reiman, Eric M. , Chen, Kewei , Thiyyagura, Pradeep , Liu, Xiaofen , Koeppe, Robert A. , Caselli, Richard J.

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_15 | Pages: No page available

10.1016/j.jalz.2014.07.069 Get It

P2‐141: BRAIN‐DERIVED NEUROTROPHIC FACTOR (BDNF) POLYMORPHISMS ARE ASSOCIATED WITH DIFFERENTIAL RATES OF AMYLOID ACCUMULATION AND COGNITIVE DECLINE IN COGNITIVELY NORMAL OLDER ADULTS
Acosta, Jazmin I., Fleisher, Adam , Reschke, Cole, Bauer, Robert, Caselli, Richard J., Weiner, Michael W. , Reiman, Eric M. , Geda, Yonas E. , Stokin, Gorazd B. , Thiyyagura, Pradeep , Lu, Bai , Caselli, Richard J. , Chen, Kewei

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_13 | Pages: No page available

10.1016/j.jalz.2014.05.816 Get It

Pituitary adenylate cyclase–activating polypeptide is reduced in Alzheimer disease
Han, Pengcheng, Liang, Winnie S. , Baxter, Leslie C. , Yin, Junxiang , Tang, Zhiwei , Beach, Thomas G. , Caselli, Richard J., Reiman, Eric M. , Shi, Jiong , Baxter, Leslie C. , Caselli, Richard J.

Neurology | April 10, 2014 | Volume: 82 | Issue: 19 | Pages: 1724-1728

10.1212/wnl.0000000000000417 Get It

P4‐284: Independent and epistatic effects of Val66Met BDNF and ApoE polymorphisms on BETA‐AMYLOID deposition in cognitively normal individuals using PiB‐PET imaging
Huentelman, Matthew J. , Corneveaux, Jason J., Roontiva, Auttawut, Caselli, Richard J. , Fleisher, Adam , Bai, Lu , Reiman, Eric M. , During, Emmanuel , Elahi, Fanny M. , Chen, Kewei , Thiyyagura, Pradeep , Liu, Xiaofen

Alzheimer's & Dementia | March 29, 2014 | Volume: 8 | Issue: 4S_Part_21 | Pages: No page available

10.1016/j.jalz.2013.08.065 Get It

P1–334: Development and implementation of the National Alzheimer's Prevention Registry
High, Nellie, Aisen, Paul , Albert, Marilyn, Brown, Kyle, Comer, Meryl, Petersen, Ronald C. , Strobel, Gabrielle, Weiner, Michael W. , Tariot, Pierre N. , Reiman, Eric M. , Langbaum, Jessica B. S. , Cummings, Jeffrey L. , Manly, Jennifer J. , Sperling, Reisa Anne

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2013.05.560 Get It

DT‐01–06: Baseline FDG‐PET and volumetric MRI predicts Alzheimer's disease conversion from mild cognitive impairment: An ADNI study
Stonnington, Cynthia M. , Ayutyanont, Napatkamon , Reschke, Cole, Thyyagura, Pradeep, Protas, Hillary , Roontiva, Auttawut, Parks, Stephanie, Bauer, Robert, Lee, Wendy , Jagust, William, Foster, Norman L. , Weiner, Michael W. , Fleisher, Adam , Reiman, Eric M. , Chen, Kewei , Liu, Xiaofen , Koeppe, Robert A.

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_21 | Pages: No page available

10.1016/j.jalz.2013.08.007 Get It

O2–03–01: Validation of the Alzheimer's Prevention Initiative Composite Cognitive Test Score
Ayutyanont, Napatkamon , Hendrix, Suzanne , Fleisher, Adam , Caselli, Richard J. , Monsell, Sarah E. , Tariot, Pierre N. , Reiman, Eric M. , Langbaum, Jessica B. S. , Chen, Kewei , Kukull, Walter A. , Bennett, David A.

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_8 | Pages: No page available

10.1016/j.jalz.2013.04.147 Get It

Fibrillar amyloid correlates of preclinical cognitive decline
Stonnington, Cynthia M. , Chen, Kewei , Lee, Wendy , Locke, Dona E.C. , Dueck, Amylou C., Roontiva, Auttawut, Fleisher, Adam , Caselli, Richard J. , Reiman, Eric M. , Dueck, Amylou C. , Liu, Xiaofen , Dueck, A. C. , Locke, Dona E C

Alzheimer's & Dementia | April 16, 2013 | Volume: 10 | Issue: 1 | Pages: No page available

10.1016/j.jalz.2013.01.009 Get It

AbstractBackgroundIt is not known whether preclinical cognitive decline is associated with fibrillar β‐amyloid (Aβ) deposition irrespective of apolipoprotein E (APOE) ε4 status.MethodsFrom a prospective observational study of 623 cognitively normal individuals, we identified all subjects who showed preclinical decline of at least 2 standard deviations beyond the decline of the entire group in memory or executive function. Fourteen decliners were matched by APOE ε4 gene dose, age, sex, and education with 14 nondecliners. Dynamic Pittsburgh compound B (PiB) positron emission tomography (PET) scans, the Logan method, statistical parametric mapping, and automatically labeled regions of interest were used to characterize and compare cerebral‐to‐cerebellar PiB distribution volume ratios (DVRs), reflecting fibrillar Aβ burden.ResultsAt P < .005 (uncorrected), decliners had significantly greater DVRs in comparison to nondecliners.ConclusionsAsymptomatic longitudinal neuropsychological decline is associated with subsequent increased fibrillar amyloid deposition, even when controlling for APOE ε4 genotype.
Subjective cognitive decline: Self and informant comparisons
Caselli, Richard J. , Chen, Kewei , Locke, Dona E.C. , Lee, Wendy , Roontiva, Auttawut, Bandy, Dan, Fleisher, Adam , Reiman, Eric M. , Locke, Dona E C

Alzheimer's & Dementia | April 4, 2013 | Volume: 10 | Issue: 1 | Pages: 93-98

10.1016/j.jalz.2013.01.003 Get It

AbstractBackgroundIt is unclear whether self‐ or informant‐based subjective cognition better distinguishes emotional factors from early‐stage Alzheimer's disease (AD).MethodsHealthy members (n = 447) of the Arizona apolipoprotein E (APOE) cohort and their informants completed the self and informant paired Multidimensional Assessment of Neurodegenerative Symptoms questionnaire (MANS).ResultsDecline on the MANS was endorsed by 30.6% of members and 26.2% of informants. Self‐ and informant‐based decliners had higher scores of psychological distress and slightly lower cognitive scores than nondecliners. Over the next 6.7 years, 20 developed mild cognitive impairment (MCI). Converters were older at entry than nonconverters (63.8 [7.0] vs 58.8 [7.3] years, P = .003), 85% were APOE ε4 carriers (P < .0001), and they self‐endorsed decline earlier than informants (58.9 [39.2] vs 28.0 [40.4] months before MCI; P = .002).ConclusionsSelf‐ and informant‐based subjective decline correlated with greater psychological distress and slightly lower cognitive performance. Those with incident MCI generally self‐endorsed decline earlier than informants.
Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions
Burns, Christine , Chen, Kewei , Kaszniak, Alfred W., Lee, Wendy , Alexander, Gene E. , Bandy, Daniel, Fleisher, Adam , Caselli, Richard J. , Reiman, Eric M.

Neurology | March 28, 2013 | Volume: 80 | Issue: 17 | Pages: 1557-1564

10.1212/wnl.0b013e31828f17de Get It